Search filters

List of works by Erik Eliasson

A clinically significant interaction between warfarin and simvastatin is unique to carriers of the CYP2C9*3 allele

scientific article

A limited number of prescribed drugs account for the great majority of drug-drug interactions

scientific article

A method to model anticipatory postural control in driver braking events.

scientific article

Accumulation of celecoxib with a 7-fold higher drug exposure in individuals homozygous for CYP2C9*3.

scientific article published in March 2006

Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization

scientific article published in 2006

Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction

scientific article

Amyloid fibril formation by pulmonary surfactant protein C

scientific article published on 01 December 1999

Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk

scientific article published on 01 April 2002

Beneficial vasoactive endothelial effects of fluvastatin: focus on prostacyclin and nitric oxide

scientific article published on 07 January 2011

Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes

scientific article published on 9 April 2003

Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymes

scientific article published in February 2005

Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants-a Swedish, register-based cohort study in atrial fibrillation outpatients

scientific article published on 07 October 2020

CYP2C9 genetic variants and losartan oxidation in a Turkish population.

scientific article

CYP2D6 and adjuvant tamoxifen: possible differences of outcome in pre- and post-menopausal patients

scientific article published in April 2013

Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients

scientific article published on 9 February 2010

Clinically significant CYP2C inhibition by noscapine but not by glucosamine.

scientific article published on 28 July 2010

Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.

scientific article published on September 1996

Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholics

scientific article published on 01 July 1996

Detrusitol and memory impairment

scientific article published in February 2007

Differences in CYP2C9 Genotype and Enzyme Activity Between Swedes and Koreans of Relevance for Personalized Medicine: Role of Ethnicity, Genotype, Smoking, Age, and Sex

scholarly article by Fazleen H.M. Hatta published in June 2015

Drug metabolism is dynamic. It is as adaptable as the immune system

scientific article published on 01 July 1991

Drug-drug Interaction between Losartan and Paclitaxel in Human Liver Microsomes with Different CYP2C8 Genotypes

scientific article published on 23 December 2014

Drug–drug interactions that reduce the formation of pharmacologically active metabolites: a poorly understood problem in clinical practice

scientific article published on December 1, 2010

Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the LIFE study

scientific article published in February 2010

Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease.

scientific article published on November 1993

Ethanol-inducible cytochrome P4502E1: regulation, enzymology and molecular biology.

scientific article

Ethnicity and adverse drug reactions

scientific article published on May 2006

Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis.

scientific article published on November 1998

Hormone controlled phosphorylation and degradation of CYP2B1 and CYP2E1 in isolated rat hepatocytes

scientific article published in January 1991

Hormone- and substrate-regulated intracellular degradation of cytochrome P450 (2E1) involving MgATP-activated rapid proteolysis in the endoplasmic reticulum membranes

scientific article published on 01 August 1992

Hydroxylation of acetone by ethanol- and acetone-inducible cytochrome P-450 in liver microsomes and reconstituted membranes

scientific article published in February 1986

Immunochemical identification of hepatic protein adducts derived from estragole.

scientific article published on August 1998

Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy

scientific article published in October 2008

Increased omeprazole metabolism in carriers of the CYP2C19*17 allele; a pharmacokinetic study in healthy volunteers

scientific article published on 20 February 2008

Influence of simvastatin on the thromboxane and prostacyclin pathways, in vitro and in vivo

scientific article published in January 2013

Institutional profile: Karolinska Institutet

scientific article published on 01 December 2012

Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis.

scientific article published on November 1998

Intra-individual variability in urinary losartan oxidation ratio, an in vivo marker of CYP2C9 activity

scientific article published on August 2002

Kinetics of omeprazole and escitalopram in relation to the CYP2C19*17 allele in healthy subjects

scientific article published on 25 July 2008

Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms

scientific article published in November 2002

Losartan competitively inhibits CYP2C8-dependent paclitaxel metabolism in vitro.

scientific article published in January 2014

Mutations of the CYP2C9 gene and the response to warfarin

scientific article published in March 2001

NADPH dependent activation of microsomal glutathione transferase 1.

scientific article published in March 2004

Nationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions

scientific article

Oxidation of celecoxib by polymorphic cytochrome P450 2C9 and alcohol dehydrogenase

scientific article

Pharmacogenetic contribution to individualized treatment. Severe adverse effects can be avoided

scientific article published in May 2008

Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype

scientific article published in January 2002

Posaconazole concentrations in human tissues after allogeneic stem cell transplantation

scientific article published on 2 June 2014

Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).

scientific article published on 28 December 2012

Renal transplantation in patients with lupus nephritis

scientific article published on July 2014

Risperidone metabolic ratio as a biomarker of individual CYP2D6 genotype in schizophrenic patients

scientific article published on 20 March 2014

Role of CYP2C9 polymorphism in losartan oxidation

scientific article published in July 2001

Roles of different CYP enzymes in the formation of specific fluvastatin metabolites by human liver microsomes

scientific article published on 6 August 2009

Seasonal variation in blood drug concentrations and a potential relationship to vitamin D.

scientific article published on 24 February 2011

Serum levels of 25-hydroxyvitamin D and the CYP3A biomarker 4β-hydroxycholesterol in a high-dose vitamin D supplementation study

scientific article published on 5 February 2013

Severely diminished response to vitamin K-treatment for self-inflicted warfarin intoxication in a patient genotyped as CYP2C9*3*3.

scientific article published on 30 May 2009

Significant reduction of sertraline plasma levels by carbamazepine and phenytoin

scientific article

Stable expression of human cytochrome P450 2E1 in V79 Chinese hamster cells.

scientific article

Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation.

scientific article published on April 1990

Substrate-regulated, cAMP-dependent phosphorylation, denaturation, and degradation of glucocorticoid-inducible rat liver cytochrome P450 3A1.

scientific article

The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants

scientific article published on 28 March 2007

The impact of CYP2C9 genetics and oral contraceptives on cytochrome P450 2C9 phenotype

scientific article published in May 2004

The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro

scientific article published in December 2001

Therapeutic drug monitoring for tomorrow.

scientific article published on 03 May 2013

UGT1A4*3 encodes significantly increased glucuronidation of olanzapine in patients on maintenance treatment and in recombinant systems

scientific article published on 20 June 2012

Use of molecular simulation for mapping conformational CYP2E1 epitopes

scientific article published on 28 September 2004

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

scientific article published in January 1999

Vitamin D and drug-metabolising enzymes

scientific article

["Silent" interactions are often missed. Different combinations of pharmaceuticals can result in non-drug effect]

scientific article published on 01 June 2010